| 000 | 01446 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514034618.0 | ||
| 264 | 0 | _c20030725 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a0141-9854 | ||
| 024 | 7 |
_a10.1046/j.1365-2257.2002.00201.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlexandrakis, M G | |
| 245 | 0 | 0 |
_aCorrelation between the uptake of Tc-99m-sestaMIBI and prognostic factors in patients with multiple myeloma. _h[electronic resource] |
| 260 |
_bClinical and laboratory haematology _cJun 2002 |
||
| 300 |
_a155-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xcomplications |
| 650 | 0 | 4 |
_aOsteolysis _xdiagnosis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 |
_aTechnetium Tc 99m Sestamibi _xpharmacokinetics |
| 650 | 0 | 4 | _aTomography, Emission-Computed |
| 700 | 1 | _aKyriakou, D S | |
| 700 | 1 | _aPassam, F H | |
| 700 | 1 | _aMalliaraki, N | |
| 700 | 1 | _aChristophoridou, A V | |
| 700 | 1 | _aKarkavitsas, N | |
| 773 | 0 |
_tClinical and laboratory haematology _gvol. 24 _gno. 3 _gp. 155-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2257.2002.00201.x _zAvailable from publisher's website |
| 999 |
_c11962575 _d11962575 |
||